138 related articles for article (PubMed ID: 27341548)
1. An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.
Barbon E; Pignani S; Branchini A; Bernardi F; Pinotti M; Bovolenta M
Sci Rep; 2016 Jun; 6():28304. PubMed ID: 27341548
[TBL] [Abstract][Full Text] [Related]
2. Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts.
Pignani S; Zappaterra F; Barbon E; Follenzi A; Bovolenta M; Bernardi F; Branchini A; Pinotti M
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):619-624. PubMed ID: 31005673
[TBL] [Abstract][Full Text] [Related]
3. Lethal factor VII deficiency due to novel mutations in the F7 promoter: functional analysis reveals disruption of HNF4 binding site.
Giansily-Blaizot M; Lopez E; Viart V; Chafa O; Tapon-Bretaudière J; Claustres M; Taulan M
Thromb Haemost; 2012 Aug; 108(2):277-83. PubMed ID: 22628013
[TBL] [Abstract][Full Text] [Related]
4. N-Glycan-calnexin interactions in human factor VII secretion and deficiency.
Wang H; Wang L; Li S; Dong N; Wu Q
Int J Biochem Cell Biol; 2019 Aug; 113():67-74. PubMed ID: 31185295
[TBL] [Abstract][Full Text] [Related]
5. Two novel mutations in the human coagulation factor VII promoter.
Kavlie A; Hiltunen L; Rasi V; Prydz H
Thromb Haemost; 2003 Aug; 90(2):194-205. PubMed ID: 12888866
[TBL] [Abstract][Full Text] [Related]
6. Mutation in the factor VII hepatocyte nuclear factor 4α-binding site contributes to factor VII deficiency.
Zheng XW; Kudaravalli R; Russell TT; DiMichele DM; Gibb C; Russell JE; Margaritis P; Pollak ES
Blood Coagul Fibrinolysis; 2011 Oct; 22(7):624-7. PubMed ID: 21760481
[TBL] [Abstract][Full Text] [Related]
7. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter.
Arbini AA; Pollak ES; Bayleran JK; High KA; Bauer KA
Blood; 1997 Jan; 89(1):176-82. PubMed ID: 8978290
[TBL] [Abstract][Full Text] [Related]
8. Factor VII Deficiency Due to Compound Heterozygosity for the p.Leu13Pro Mutation and a Novel Mutation in the HNF4 Binding Region (-58G>C) in the F7 Promoter.
Osaki K; Sogabe Y; Seki R; Nakamura T; Morishige S; Oku E; Takata Y; Mouri F; Yoshimoto K; Nagafuji K; Okamura T
Kurume Med J; 2022 Nov; 67(2.3):83-89. PubMed ID: 36123027
[TBL] [Abstract][Full Text] [Related]
9. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter.
Carew JA; Pollak ES; High KA; Bauer KA
Blood; 1998 Sep; 92(5):1639-45. PubMed ID: 9716591
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Furlan Freguia C; Toso R; Pollak ES; Arruda VR; Pinotti M; Bernardi F
Haematologica; 2004 Dec; 89(12):1504-9. PubMed ID: 15590402
[TBL] [Abstract][Full Text] [Related]
11. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency.
Carew JA; Pollak ES; Lopaciuk S; Bauer KA
Blood; 2000 Dec; 96(13):4370-2. PubMed ID: 11110717
[TBL] [Abstract][Full Text] [Related]
12. In vitro expression of mutant factor VII proteins and characterization of their clinical significance.
Mashayekhi A; Shahbazi S; Omrani M; Mahdian R
Mol Med Rep; 2018 Feb; 17(2):2738-2742. PubMed ID: 29207137
[TBL] [Abstract][Full Text] [Related]
13. Two naturally occurring mutations on FVII gene (S363I-W364C) altering intrinsic catalytic activity.
Peyvandi F; De Cristofaro R; Akhavan S; Carew JA; Landolfi R; Bauer KA; Mannucci PM
Thromb Haemost; 2002 Nov; 88(5):750-5. PubMed ID: 12428089
[TBL] [Abstract][Full Text] [Related]
14. Two double heterozygous mutations in the F7 gene show different manifestations.
Nagaizumi K; Inaba H; Suzuki T; Hatta Y; Hagiwara T; Amano K; Arai M; Fukutake K
Br J Haematol; 2002 Dec; 119(4):1052-8. PubMed ID: 12472587
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression.
Suzuki A; Miyawaki Y; Okuyama E; Murata M; Ando Y; Kato I; Takagi Y; Takagi A; Murate T; Saito H; Kojima T
Biochem J; 2013 Jan; 449(1):231-9. PubMed ID: 23050902
[TBL] [Abstract][Full Text] [Related]
16. Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications.
Shahbazi S; Mahdian R
Iran Biomed J; 2019 May; 23(3):165-74. PubMed ID: 30797223
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a factor VII deficient patient supports the importance of the second epidermal growth factor-like domain.
D'Andrea G; Bossone A; Lupone MR; Peyvandi F; Maisto G; Perricone F; Grandone E; Margaglione M
Haematologica; 2004 Aug; 89(8):979-84. PubMed ID: 15339682
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.
Giansily-Blaizot M; Thorel D; Khau Van Kien P; Behar C; Romey MC; Mugneret F; Schved JF; Claustres M
Br J Haematol; 2007 Aug; 138(3):359-65. PubMed ID: 17614823
[TBL] [Abstract][Full Text] [Related]
19. Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII.
Suzuki K; Sugawara T; Ishida Y; Suwabe A
Thromb Res; 2013 Feb; 131(2):166-72. PubMed ID: 23141848
[TBL] [Abstract][Full Text] [Related]
20. The paradoxical association between inherited factor VII deficiency and venous thrombosis.
Marty S; Barro C; Chatelain B; Fimbel B; Tribout B; Reynaud J; Schved JF; Giansily-Blaizot M
Haemophilia; 2008 May; 14(3):564-70. PubMed ID: 18282149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
